The present disclosure generally relates to systems and medical sponge for cleaning needleless connectors. A medical sponge can include a shaped foam configured to engage a portion of the needless connector and a disinfecting solution applied to the shaped foam. A system can include the medical sponge and a liquid-impermeable pouch in which the medical sponge is separately retained. The medical sponge can include highly-abrasive and highly-conforming foam material in place of wipes or other sponge products. The foam material may be an open-cell micro abrasive material such as melamine foam. The foam material may contain disinfecting solutions such as isopropyl alcohol, chlorhexidine gluconate, or povidone-iodine.

The present disclosure generally relates to systems and medical sponge for cleaning needleless connectors. A medical sponge can include a shaped foam configured to engage a portion of the needless connector and a disinfecting solution applied to the shaped foam. A system can include the medical sponge and a liquid-impermeable pouch in which the medical sponge is separately retained. The medical sponge can include highly-abrasive and highly-conforming foam material in place of wipes or other sponge products. The foam material may be an open-cell micro abrasive material such as melamine foam. The foam material may contain disinfecting solutions such as isopropyl alcohol, chlorhexidine gluconate, or povidone-iodine.

An anti-pathogen structure includes a resin structure having a plurality of openings in a surface of the resin structure, wherein the resin structure has an antimicrobial activity or an antiviral activity.

An anti-pathogen structure includes a resin structure having a plurality of openings in a surface of the resin structure, wherein the resin structure has an antimicrobial activity or an antiviral activity.

A photosensitizer formulation can be disposed on or in a container. The photosensitizer formulation, when in contact with molecular oxygen and activated by light or ultrasound, produces microbicidal singlet oxygen. A variety of different arrangements and applications are described. For example, an air flow device may also be included to generate a flow of air through or over the photosensitizer formulation.

The present disclosure generally relates to systems for disinfecting Central Venous Catheter (CVC) system ports that use highly-abrasive and highly-conforming foam material in place of wipes or other sponge products, and methods for using such systems. The foam material may be an open-cell microabrasive material such as melamine foam. The foam material may contain disinfecting solutions such as isopropyl alcohol, chlorhexidine gluconate, or povidone-iodine.

The present disclosure generally relates to systems for disinfecting Central Venous Catheter (CVC) system ports that use highly-abrasive and highly-conforming foam material in place of wipes or other sponge products, and methods for using such systems. The foam material may be an open-cell microabrasive material such as melamine foam. The foam material may contain disinfecting solutions such as isopropyl alcohol, chlorhexidine gluconate, or povidone-iodine.

The present invention is directed to chitosan-derivative compounds and structures, methods of making chitosan-derivative compounds and methods for controlling, inhibiting and enhancing microbial populations in a variety of environments. The present invention is also directed to the control, inhibition and enhancement of microbial populations in animals, particularly humans. The microbial populations include bacteria, viruses and other pathogens where control of microbial populations are a necessity. The chitosan-derivative compounds of the present invention include chitosan-arginine compounds, related chitosan-L/D unnatural amino acid compounds, chitosan-acid amine compounds, chitosan-L/D natural amino acid derivative compounds, co-derivatives of the chitosan-derivative compounds, salts of the chitosan derivative compounds, and chitosan-guanidine compounds.

The present invention is directed to chitosan-derivative compounds and structures, methods of making chitosan-derivative compounds and methods for controlling, inhibiting and enhancing microbial populations in a variety of environments. The present invention is also directed to the control, inhibition and enhancement of microbial populations in animals, particularly humans. The microbial populations include bacteria, viruses and other pathogens where control of microbial populations are a necessity. The chitosan-derivative compounds of the present invention include chitosan-arginine compounds, related chitosan-L/D unnatural amino acid compounds, chitosan-acid amine compounds, chitosan-L/D natural amino acid derivative compounds, co-derivatives of the chitosan-derivative compounds, salts of the chitosan derivative compounds, and chitosan-guanidine compounds.

An open-cell foam structure that is used to detect and remove substances from water or air.